Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

France: Ipsen adds to late-stage oncology pipeline with acquisition of Kartos Therapeutics

Buy Out Nick Herbert -
In its second major deal announcement of the week following news of its proposed acquisition of Memo Therapeutics for in excess of €700m, France based listed biopharma, Ipsen, has agreed to acquire US-based Kartos Therapeutics, a clinical-stage biopharma, for up to US$1.75bn. Ipsen will pay US$450m, with Kartos shareholders...

UK: Caidya announces strategic combination with Simbec-Orion

M&A Nick Herbert -
Global CRO, Caidya, has announced a strategic combination with UK-based CRO, Simbec-Orion, designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion brings together complementary strengths to create a more complete development partner for innovative biopharma companies. “This strategic combination brings together complementary strengths to create a more complete development partner for innovators,” said Barbara Lopez Kunz, CEO of Caidya. “By combining Simbec-Orion’s European presence and early-phase expertise with Caidya’s global platform, we can support sponsors from first-in-human through registration while helping them thrive where...